MENU
+Compare
ADIL
Stock ticker: NASDAQ
AS OF
Jun 4 closing price
Price
$0.67
Change
+$0.01 (+1.52%)
Capitalization
5.28M

ADIL Adial Pharmaceuticals Forecast, Technical & Fundamental Analysis

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADIL with price predictions
Jun 04, 2025

Aroon Indicator for ADIL shows an upward move is likely

ADIL's Aroon Indicator triggered a bullish signal on May 08, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 90 similar instances where the Aroon Indicator showed a similar pattern. In of the 90 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ADIL just turned positive on May 19, 2025. Looking at past instances where ADIL's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ADIL crossed bullishly above the 50-day moving average on May 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADIL advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADIL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 34 cases where ADIL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADIL as a result. In of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ADIL moved below its 50-day moving average on June 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.481) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). ADIL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (265.014).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADIL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADIL is expected to report earnings to fall 82.35% to -5 cents per share on August 15

Adial Pharmaceuticals ADIL Stock Earnings Reports
Q2'23
Est.
$-0.06
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.05
Q1'23
Est.
$-0.10
Q4'22
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -34 cents, beating the estimate of -38 cents. With 45.05K shares outstanding, the current market capitalization sits at 5.28M.
A.I. Advisor
published General Information

General Information

a developer of medications to treat addiction and related disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
4870 Sadler Road
Phone
+1 804 487-8196
Employees
7
Web
https://www.adialpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRX2.230.13
+6.19%
Mangoceuticals Inc
RAPT1.020.03
+3.24%
RAPT Therapeutics
BRKR37.830.43
+1.15%
Bruker Corp
PACK3.420.02
+0.59%
Ranpak Holdings Corp
VSEC131.16-0.21
-0.16%
VSE Corp

ADIL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+1.44%
SYRE - ADIL
39%
Loosely correlated
-0.30%
VANI - ADIL
37%
Loosely correlated
-1.75%
VTVT - ADIL
29%
Poorly correlated
-1.84%
BPMUF - ADIL
28%
Poorly correlated
N/A
GDTC - ADIL
27%
Poorly correlated
-4.73%
More